Initiative for Early Lung Cancer Research on Treatment: Development of Study Design and Pilot Implementation

Keyphrases

• Early-stage Lung Cancer 100%
• Cancer Research 100%
• Treatment Development 100%
• Quality of Life 66%
• In(III) 33%
• Surgeons 33%
• Operative Time 33%
• Operative Complications 33%
• Computed Tomographic 33%
• Surgical Patients 33%
• Treatment Alternatives 33%
• Postoperative Morbidity 33%
• Lymph Node Metastasis 33%
• Treatment Results 33%
• Optimal Treatment 33%
• Treatment Quality 33%
• Stage I NSCLC 33%
• Institutional Review Board 33%
• Pulmonary Function 33%
• HIPAA 33%
• 3 to 5 Years 33%
• Postsurgical 33%
• Lobectomy 33%
• Extent of Surgery 33%
• Primary Lung Cancer 33%
• New Primary 33%
• Pre-surgical 33%
• Lung Tissue 33%
• Sublobar Resection 33%
• Multi-institutional 33%
• Long-term Treatment Outcomes 33%
• Patient Views 33%
• Lymph Node Resection 33%
• Timely Manner 33%
• Screening for Lung Cancer 33%
• Large Database 33%
• Surgeon Opinion 33%
• Mediastinal Lymph Nodes 33%

Medicine and Dentistry

• Lung Cancer 100%
• Cancer Research 100%
• Treatment Development 100%
• Quality of Life 40%
• Surgeon 40%
• Non-Small Cell Lung Cancer 20%
• Recurrent Disease 20%
• Retroperitoneal Lymph Node Dissection 20%
• Cohort Analysis 20%
• Lymph Node Metastasis 20%
• Lung Function 20%
• Lobectomy 20%
• Hexafluronium Bromide 20%
• Mediastinal Lymph Node 20%
• Lung 20%
• Treatment Outcome 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Cancer 100%
• Recurrent Disease 20%
• Cohort Study 20%
• Lymph Node Metastasis 20%
• Hexafluronium Bromide 20%